\-\ Texto\\:\\ \ \(0\)\
\-\ normal\\ neck\\ exam\\.\ \(0\)\
\-\ alkaline\\ phosphate\\ 1252\\ u\\/l\\ \\(normal\\ 38\\-126\\)\ \(0\)\
\-\ phosphorus\\ low\\,\\ calcium\\ high\ \(0\)\
\-\ surgery\\:\\ 95\\%\\ successful\\,\\ often\\ perform\\ 3\\.5\\ parathyroidectomy\\ and\\ place\\ the\\ 0\\.5\\ most\\ normal\\ tissue\\ in\\ forearm\\.\ \(0\)\
\-\ t99m\\-sestamibi\\,\\ dose\\:\\ 20\\ mci\\ i\\.v\\.\ \(0\)\
\-\ scan\\ 20\\ minutes\\ and\\ 2\\ 1\\/2\\ hours\\ after\\ dosing\\.\\ patient\\ supine\\ with\\ chin\\ up\\ and\\ neck\\ extended\\ \\(sternal\\ and\\ chin\\ markers\\)\\.\ \(0\)\
\-\ focal\\ radiotracer\\ uptake\\ within\\ region\\ of\\ the\\ right\\ and\\ left\\ superior\\ poles\\ of\\ the\\ thyroid\\ on\\ delayed\\ images\\ consistent\\ with\\ parathyroid\\ hyperplasia\\/adenomas\\.\ \(0\)\
\-\ hyperparathyroidism\ \(35\)\
\-\ parathyroid\\ adenoma\ \(27\)\
\-\ parathyroid\\ adenoma\ \(27\)\
\-\ parathyroid\\ hyperplasia\ \(5\)\
\-\ follicular\\ thyroid\\ adenoma\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ 40\\ y\\.o\\.\\ female\\ with\\ elevated\\ serum\\ calcium\\ and\\ parathyroid\\ hormone\\ levels\\.\\ \\ please\\ evaluate\\ for\\ parathyroid\\ adenoma\\.\ \(0\)\
\-\ findings\\:\ \(65\)\
\-\ \\â\\€\\¢t99m\\-sestamibi\\,\\ dose\\:\\ 20\\ mci\\ i\\.v\\.\ \(0\)\
\-\ \\â\\€\\¢scan\\ 20\\ minutes\\ and\\ 2\\ 1\\/2\\ hours\\ after\\ dosing\\.\\ patient\\ supine\\ with\\ chin\\ up\\ and\\ neck\\ extended\\ \\(sternal\\ and\\ chin\\ markers\\)\ \(0\)\
\-\ \\â\\€\\¢sestamibi\\ demonstrates\\ slower\\ washout\\ from\\ parathyroid\\ adenomas\\ and\\ hyperplastic\\ parathyroid\\ glands\\ compared\\ with\\ surrounding\\ thyroid\\ tissue\\.\ \(0\)\
\-\ \\â\\€\\¢sensitivity\\ for\\ parathyroid\\ adenomas\\ 90\\%\\.\\ \\(less\\ for\\ hyperplasia\\)\ \(0\)\
\-\ \\â\\€\\¢false\\ positives\\:\\ follicular\\ thyroid\\ adenoma\\,\\ lymphoma\ \(0\)\
\-\ \\â\\€\\¢dual\\ imaging\\ has\\ problems\\:\\ 1\\.\\ misregistration\\ causing\\ inaccurate\\ subtraction\\,\\ 2\\.\\ other\\ lesions\\ \\(mets\\)\\ can\\ mimic\\ parathyroid\\ adenomas\\ and\\ take\\ up\\ tl\\-201\\,\\ 3\\.\\ relative\\ uptake\\ of\\ tl\\-201\\ and\\ tc\\-99m\\ pertechnetate\\ may\\ be\\ altered\\ by\\ other\\ pathology\\ \\(mng\\,\\ follicular\\ adenoma\\)\ \(0\)\
\-\ focal\\ radiotracer\\ uptake\\ within\\ region\\ of\\ the\\ right\\ and\\ left\\ superior\\ poles\\ of\\ the\\ thyroid\\ on\\ delayed\\ images\\ consistent\\ with\\ parathyroid\\ hyperplasia\\/adenomas\\.\ \(0\)\
\-\ differential\\ diagnosis\\ and\\ discussion\\:\ \(0\)\
\-\ \\â\\€\\¢parathyroid\\ adenoma\ \(0\)\
\-\ \\â\\€\\¢parathyroid\\ hyperplasia\ \(0\)\
\-\ \\â\\€\\¢follicular\\ thyroid\\ adenoma\ \(0\)\
\-\ \\â\\€\\¢lymphoma\ \(1\)\
\-\ \\â\\€\\¢hyperactive\\ parathyroid\\ tissue\\ causes\\ increased\\ parathyroid\\ hormone\\,\\ elevated\\ serum\\ calcium\\ and\\ excretion\\.\ \(0\)\
\-\ \\â\\€\\¢women\\:men\\ 2\\:1\\,\\ 85\\%\\ of\\ hyperparathyroidism\\ caused\\ by\\ a\\ single\\ pt\\ adenoma\\.\\ 15\\%\\ from\\ hyperplasia\\.\ \(0\)\
\-\ \\â\\€\\¢majority\\ have\\ 4\\ glands\\,\\ but\\ variants\\ often\\ occur\\.\\ \ \(0\)\
\-\ \\â\\€\\¢superior\\ 2\\ glands\\ derive\\ from\\ 4th\\ pharyngeal\\ pouch\\ \\(c\\ cells\\ of\\ thyroid\\)\\ and\\ often\\ can\\ be\\ within\\ the\\ gland\\.\\ inferior\\ 2\\ glands\\ derive\\ from\\ 3rd\\ pp\\ and\\ may\\ migrate\\ anywhere\\ towards\\ thymus\\.\ \(0\)\
\-\ \\â\\€\\¢most\\ often\\ within\\ 2\\ cm\\ and\\ 1cm\\ of\\ thyroid\\,\\ respectively\\.\\ imaging\\ is\\ crucial\\ for\\ operative\\ planning\\.\ \(0\)\
\-\ \\â\\€\\¢typically\\ diagnosed\\ by\\ serum\\ calcium\\ and\\ parathyroid\\ levels\\.\\ option\\ to\\ medically\\ follow\\ if\\ levels\\ \\<11\\.5\\ mg\\/dl\\.\ \(0\)\
\-\ \\â\\€\\¢surgery\\ is\\ 95\\%\\ successful\\,\\ often\\ perform\\ 3\\.5\\ parathyroidectomy\\ and\\ place\\ 0\\.5\\ most\\ normal\\ tissue\\ in\\ forearm\\.\ \(0\)\
\-\ final\\ diagnosis\\:\ \(0\)\
\-\ parathyroid\\ adenoma\\ \ \(6\)\
\-\ references\\:\ \(0\)\
\-\ \\â\\€\\¢taillefer\\ r\\,\\ boucher\\ y\\,\\ potrin\\ c\\.\\ detection\\ and\\ localization\\ of\\ parathyroid\\ adenomas\\ in\\ patients\\ with\\ hyperparathyroidism\\ using\\ single\\ radionuclide\\ imagine\\ procedure\\ with\\ tc\\-99m\\-sestamibi\\ \\(double\\-phase\\ study\\)\\.\\ j\\ nucl\\ med\\/\\ 33\\:1801\\-1805\\,\\ 1992\\.\\ \\(mibi\\ scan\\ correctly\\ detected\\ and\\ localized\\ 19\\/21\\ adenomas\\ \\(90\\%\\)\\.\\ \ \(0\)\
\-\ \\â\\€\\¢gayed\\ iw\\,\\ et\\ al\\.\\ the\\ value\\ of\\ tc\\-99m\\-sestamibi\\ spect\\/ct\\ over\\ conventional\\ spect\\ in\\ the\\ evaluation\\ of\\ parathyroid\\ adenomas\\ or\\ hyperplasia\\.\\ j\\ nucl\\ med\\ 46\\(2\\)\\:248\\-252\\,\\ 2005\\.\ \(0\)\
\-\ \\â\\€\\¢rauth\\ jd\\,\\ sessions\\ rb\\,\\ ziessman\\ ha\\:\\ comparisons\\ of\\ tc\\-mibi\\ and\\ tl\\-201\\/tc\\-99m\\ for\\ diagnosis\\ of\\ primary\\ hyperparathyroidism\\.\\ clin\\ nucl\\ med\\ 21\\:602\\-608\\,\\ 1996\\.\\ \\(tc\\-99m\\ mibi\\ yielded\\ 13\\ true\\-positive\\ and\\ 1\\ false\\-negative\\ result\\.\\ thallium\\-201\\/\\ tc\\-99m\\ pertechnetate\\ imaging\\ yielded\\ eight\\ true\\-positive\\,\\ four\\ false\\-negative\\,\\ and\\ two\\ nondiagnostic\\ studies\\)\ \(0\)\
\-\ \\â\\€\\¢thrall\\ jh\\,\\ ziessman\\ ha\\.\\ nuclear\\ medicine\\:\\ the\\ requisites\\.\\ 2nd\\ ed\\.\\,\\ mosby\\.chapter\\ 14\\,\\ 2001\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ parathyroid\\:\\ 0\\.5530917627112759\ \(0\)\
\-\ adenomas\\:\\ 0\\.2469158998105896\ \(0\)\
\-\ adenoma\\:\\ 0\\.21147027361656867\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.16927551752267098\ \(0\)\
\-\ thyroid\\:\\ 0\\.16676343558255038\ \(0\)\
\-\ chin\\:\\ 0\\.13796870493041086\ \(0\)\
\-\ and\\:\\ 0\\.13702633733036998\ \(0\)\
\-\ mibi\\:\\ 0\\.12725744640994302\ \(0\)\
\-\ follicular\\:\\ 0\\.1212672147528246\ \(0\)\
\-\ glands\\:\\ 0\\.11261157411594898\ \(0\)\
\-\ nucl\\:\\ 0\\.10978163681541232\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.10106435535786143\ \(0\)\
\-\ calcium\\:\\ 0\\.09583015364282937\ \(0\)\
\-\ often\\:\\ 0\\.08653759870464449\ \(0\)\
\-\ derive\\:\\ 0\\.08483829760662868\ \(0\)\
\-\ med\\:\\ 0\\.08004583389967664\ \(0\)\
\-\ parathyroidectomy\\:\\ 0\\.07462134001885525\ \(0\)\
\-\ serum\\:\\ 0\\.07135589640557295\ \(0\)\
\-\ dosing\\:\\ 0\\.07085056496418574\ \(0\)\
\-\ ziessman\\:\\ 0\\.07085056496418574\ \(0\)\
\-\ 20\\:\\ 0\\.06844898016307399\ \(0\)\
\-\ of\\:\\ 0\\.06748056602837148\ \(0\)\
\-\ pertechnetate\\:\\ 0\\.0654997500073169\ \(0\)\
\-\ yielded\\:\\ 0\\.0644043824310818\ \(0\)\
\-\ levels\\:\\ 0\\.0630861058483691\ \(0\)\
\-\ poles\\:\\ 0\\.06297080028916811\ \(0\)\
\-\ ha\\:\\ 0\\.0617289749526474\ \(0\)\
\-\ markers\\:\\ 0\\.06134933548296023\ \(0\)\
\-\ uptake\\:\\ 0\\.06118836202004953\ \(0\)\
\-\ mci\\:\\ 0\\.0606336073764123\ \(0\)\
\-\ spect\\:\\ 0\\.0606336073764123\ \(0\)\
\-\ sternal\\:\\ 0\\.05965376769046905\ \(0\)\
\-\ tissue\\:\\ 0\\.05565753640331839\ \(0\)\
\-\ forearm\\:\\ 0\\.05509103561415049\ \(0\)\
\-\ perform\\:\\ 0\\.05471899097997989\ \(0\)\
\-\ extended\\:\\ 0\\.05471899097997989\ \(0\)\
\-\ hormone\\:\\ 0\\.05401678013681923\ \(0\)\
\-\ supine\\:\\ 0\\.05320758515736513\ \(0\)\
\-\ superior\\:\\ 0\\.051734890741804984\ \(0\)\
\-\ successful\\:\\ 0\\.051512017364873965\ \(0\)\
\-\ 95\\:\\ 0\\.05030253945426367\ \(0\)\
\-\ minutes\\:\\ 0\\.05018981230953528\ \(0\)\
\-\ dose\\:\\ 0\\.04954072040799985\ \(0\)\
\-\ within\\:\\ 0\\.04886627224338214\ \(0\)\
\-\ neck\\:\\ 0\\.04867811577313404\ \(0\)\
\-\ place\\:\\ 0\\.04782775340449677\ \(0\)\
\-\ the\\:\\ 0\\.047634174534596174\ \(0\)\
\-\ lymphoma\\:\\ 0\\.047391727278453526\ \(0\)\
\-\ scan\\:\\ 0\\.04721085196179623\ \(0\)\
\-\ radiotracer\\:\\ 0\\.04630766016829076\ \(0\)\
\-\ normal\\:\\ 0\\.04331981572612479\ \(0\)\
\-\ 1252\\:\\ 0\\.04241914880331434\ \(0\)\
\-\ misregistration\\:\\ 0\\.04241914880331434\ \(0\)\
\-\ inaccurate\\:\\ 0\\.04241914880331434\ \(0\)\
\-\ mng\\:\\ 0\\.04241914880331434\ \(0\)\
\-\ boucher\\:\\ 0\\.04241914880331434\ \(0\)\
\-\ potrin\\:\\ 0\\.04241914880331434\ \(0\)\
\-\ iw\\:\\ 0\\.04241914880331434\ \(0\)\
\-\ comparisons\\:\\ 0\\.04241914880331434\ \(0\)\
\-\ 90\\:\\ 0\\.04239042735333561\ \(0\)\
\-\ from\\:\\ 0\\.042138321787932136\ \(0\)\
\-\ imaging\\:\\ 0\\.041819256219339906\ \(0\)\
\-\ with\\:\\ 0\\.04155131424645766\ \(0\)\
\-\ delayed\\:\\ 0\\.04151286541312546\ \(0\)\
\-\ most\\:\\ 0\\.04141314132748593\ \(0\)\
\-\ diagnosis\\:\\ 0\\.041251018058475725\ \(0\)\
\-\ single\\:\\ 0\\.04079224134669969\ \(0\)\
\-\ hours\\:\\ 0\\.04043220120054313\ \(0\)\
\-\ for\\:\\ 0\\.04019752421387284\ \(0\)\
\-\ up\\:\\ 0\\.03936266055455651\ \(0\)\
\-\ imagine\\:\\ 0\\.03919605753676238\ \(0\)\
\-\ nondiagnostic\\:\\ 0\\.03919605753676238\ \(0\)\
\-\ migrate\\:\\ 0\\.03815845390567321\ \(0\)\
\-\ crucial\\:\\ 0\\.03731067000942762\ \(0\)\
\-\ positives\\:\\ 0\\.03659387893847078\ \(0\)\
\-\ jd\\:\\ 0\\.03659387893847078\ \(0\)\
\-\ sessions\\:\\ 0\\.03659387893847078\ \(0\)\
\-\ elevated\\:\\ 0\\.0361648055668006\ \(0\)\
\-\ correctly\\:\\ 0\\.03597296627021042\ \(0\)\
\-\ rb\\:\\ 0\\.03597296627021042\ \(0\)\
\-\ slower\\:\\ 0\\.03542528248209287\ \(0\)\
\-\ thymus\\:\\ 0\\.034492176232602714\ \(0\)\
\-\ phosphate\\:\\ 0\\.034087578742875664\ \(0\)\
\-\ phosphorus\\:\\ 0\\.034087578742875664\ \(0\)\
\-\ subtraction\\:\\ 0\\.034087578742875664\ \(0\)\
\-\ by\\:\\ 0\\.03379207991803336\ \(0\)\
\-\ variants\\:\\ 0\\.03337078767191881\ \(0\)\
\-\ jh\\:\\ 0\\.03304997511178649\ \(0\)\
\-\ radionuclide\\:\\ 0\\.03246797428387666\ \(0\)\
\-\ hyperplastic\\:\\ 0\\.03195078200034049\ \(0\)\
\-\ focal\\:\\ 0\\.031732036875350755\ \(0\)\
\-\ region\\:\\ 0\\.031732036875350755\ \(0\)\
\-\ washout\\:\\ 0\\.03171227137256928\ \(0\)\
\-\ 1992\\:\\ 0\\.03171227137256928\ \(0\)\
\-\ anywhere\\:\\ 0\\.0308644874763237\ \(0\)\
\-\ medically\\:\\ 0\\.0308644874763237\ \(0\)\
\-\ localization\\:\\ 0\\.03031680368820615\ \(0\)\
\-\ excretion\\:\\ 0\\.03014769640536685\ \(0\)\
\-\ planning\\:\\ 0\\.03014769640536685\ \(0\)\
\-\ requisites\\:\\ 0\\.03014769640536685\ \(0\)\
\-\ pp\\:\\ 0\\.02998452395139521\ \(0\)\
\-\ alkaline\\:\\ 0\\.029826883845234527\ \(0\)\
\-\ pharyngeal\\:\\ 0\\.029826883845234527\ \(0\)\
\-\ eight\\:\\ 0\\.02967441320907441\ \(0\)\
\-\ mimic\\:\\ 0\\.02952678373710649\ \(0\)\
\-\ pouch\\:\\ 0\\.0292448830173247\ \(0\)\
\-\ towards\\:\\ 0\\.02911009277427768\ \(0\)\
\-\ consistent\\:\\ 0\\.02876485952306408\ \(0\)\
\-\ 1996\\:\\ 0\\.028727690733788523\ \(0\)\
\-\ surgery\\:\\ 0\\.028521856074789315\ \(0\)\
\-\ 1cm\\:\\ 0\\.028152893528987245\ \(0\)\
\-\ clin\\:\\ 0\\.02783929576904027\ \(0\)\
\-\ can\\:\\ 0\\.02783889327132909\ \(0\)\
\-\ detection\\:\\ 0\\.027641396209771733\ \(0\)\
\-\ other\\:\\ 0\\.027549651307355257\ \(0\)\
\-\ respectively\\:\\ 0\\.02745157647492815\ \(0\)\
\-\ mets\\:\\ 0\\.027269202598819816\ \(0\)\
\-\ conventional\\:\\ 0\\.02709371242165419\ \(0\)\
\-\ men\\:\\ 0\\.027008390068409615\ \(0\)\
\-\ value\\:\\ 0\\.027008390068409615\ \(0\)\
\-\ take\\:\\ 0\\.026924605138814884\ \(0\)\
\-\ altered\\:\\ 0\\.026924605138814884\ \(0\)\
\-\ option\\:\\ 0\\.02676143268484325\ \(0\)\
\-\ may\\:\\ 0\\.02669636939774199\ \(0\)\
\-\ in\\:\\ 0\\.026394173956843615\ \(0\)\
\-\ final\\:\\ 0\\.026021791750772738\ \(0\)\
\-\ after\\:\\ 0\\.025735363546967722\ \(0\)\
\-\ detected\\:\\ 0\\.02544381510120718\ \(0\)\
\-\ 2005\\:\\ 0\\.02520832489431943\ \(0\)\
\-\ nuclear\\:\\ 0\\.02509490615476764\ \(0\)\
\-\ 2001\\:\\ 0\\.02503921761148013\ \(0\)\
\-\ images\\:\\ 0\\.024539098630435074\ \(0\)\
\-\ 85\\:\\ 0\\.02446699583614739\ \(0\)\
\-\ 4th\\:\\ 0\\.024418304943219775\ \(0\)\
\-\ 46\\:\\ 0\\.024370118628208832\ \(0\)\
\-\ 2nd\\:\\ 0\\.024275218644829274\ \(0\)\
\-\ 3rd\\:\\ 0\\.02422848520837619\ \(0\)\
\-\ localized\\:\\ 0\\.023827764282263898\ \(0\)\
\-\ relative\\:\\ 0\\.023498427544150307\ \(0\)\
\-\ medicine\\:\\ 0\\.0233807013121306\ \(0\)\
\-\ discussion\\:\\ 0\\.023228230675970483\ \(0\)\
\-\ problems\\:\\ 0\\.023008507701178686\ \(0\)\
\-\ please\\:\\ 0\\.022251016696103226\ \(0\)\
\-\ operative\\:\\ 0\\.022251016696103226\ \(0\)\
\-\ using\\:\\ 0\\.021816126344928164\ \(0\)\
\-\ causing\\:\\ 0\\.021788530193981182\ \(0\)\
\-\ gland\\:\\ 0\\.021547268937447964\ \(0\)\
\-\ be\\:\\ 0\\.02152021308598159\ \(0\)\
\-\ four\\:\\ 0\\.021495313784795845\ \(0\)\
\-\ compared\\:\\ 0\\.021443932733976247\ \(0\)\
\-\ caused\\:\\ 0\\.02126844255681062\ \(0\)\
\-\ references\\:\\ 0\\.021147027361656866\ \(0\)\
\-\ procedure\\:\\ 0\\.021147027361656866\ \(0\)\
\-\ al\\:\\ 0\\.02107567141736996\ \(0\)\
\-\ pathology\\:\\ 0\\.02082302006571589\ \(0\)\
\-\ et\\:\\ 0\\.020778522713839\ \(0\)\
\-\ evaluate\\:\\ 0\\.02062605207767888\ \(0\)\
\-\ cells\\:\\ 0\\.02043708955323252\ \(0\)\
\-\ causes\\:\\ 0\\.020042790933245114\ \(0\)\
\-\ 13\\:\\ 0\\.020005139409418518\ \(0\)\
\-\ result\\:\\ 0\\.019857509937450602\ \(0\)\
\-\ 14\\:\\ 0\\.019803335292202375\ \(0\)\
\-\ 40\\:\\ 0\\.019507725708601587\ \(0\)\
\-\ occur\\:\\ 0\\.019507725708601587\ \(0\)\
\-\ studies\\:\\ 0\\.01945745562130097\ \(0\)\
\-\ diagnosed\\:\\ 0\\.01921394774663656\ \(0\)\
\-\ pt\\:\\ 0\\.019089109704227343\ \(0\)\
\-\ left\\:\\ 0\\.018096469058433835\ \(0\)\
\-\ less\\:\\ 0\\.018045351290258655\ \(0\)\
\-\ inferior\\:\\ 0\\.018045351290258655\ \(0\)\
\-\ 15\\:\\ 0\\.017923936095104905\ \(0\)\
\-\ surrounding\\:\\ 0\\.017690221690334056\ \(0\)\
\-\ study\\:\\ 0\\.017690221690334056\ \(0\)\
\-\ right\\:\\ 0\\.017588228232471047\ \(0\)\
\-\ patient\\:\\ 0\\.017254460866450782\ \(0\)\
\-\ differential\\:\\ 0\\.017234618887154714\ \(0\)\
\-\ primary\\:\\ 0\\.01630997476518029\ \(0\)\
\-\ evaluation\\:\\ 0\\.016176394655591387\ \(0\)\
\-\ on\\:\\ 0\\.016021972551391553\ \(0\)\
\-\ two\\:\\ 0\\.015751950466250778\ \(0\)\
\-\ if\\:\\ 0\\.015411647569272506\ \(0\)\
\-\ lesions\\:\\ 0\\.01523357222620575\ \(0\)\
\-\ cm\\:\\ 0\\.01523357222620575\ \(0\)\
\-\ low\\:\\ 0\\.015220152483019488\ \(0\)\
\-\ high\\:\\ 0\\.01507503626457816\ \(0\)\
\-\ patients\\:\\ 0\\.014921727726300885\ \(0\)\
\-\ over\\:\\ 0\\.014749031143563882\ \(0\)\
\-\ is\\:\\ 0\\.014528068431433741\ \(0\)\
\-\ increased\\:\\ 0\\.01434342466223331\ \(0\)\
\-\ follow\\:\\ 0\\.014299244398411813\ \(0\)\
\-\ exam\\:\\ 0\\.013352666566964082\ \(0\)\
\-\ demonstrates\\:\\ 0\\.013325839928402325\ \(0\)\
\-\ have\\:\\ 0\\.013250660979962284\ \(0\)\
\-\ but\\:\\ 0\\.01311662280923325\ \(0\)\
\-\ findings\\:\\ 0\\.013091120344285083\ \(0\)\
\-\ female\\:\\ 0\\.01279950552644341\ \(0\)\
\-\ has\\:\\ 0\\.012115818362533483\ \(0\)\
\-\ or\\:\\ 0\\.009227553278893495\ \(0\)\
\-\ to\\:\\ 0\\.006631182154039436\ \(0\)\
